在心力衰竭中,干性相关基因的临床应用和免疫透景观
Wenting Yan1, Yanling Li2, Gang Wang3
1Gansu University of Traditional Chinese Medicine, Lanzhou, China.
ESC heart failure
|September 14, 2024
概括
这项研究确定了七个与茎状性相关的基因,用于预测心力衰竭 (HF) 风险. 这些发现为改进HF诊断和治疗策略提供了潜力.
科学领域:
- 生物医学研究的研究.
- 基因组学就是基因组学.
- 心血管疾病是什么心血管疾病
背景情况:
- 心力衰竭 (HF) 是一个主要的全球健康问题.
- 茎在心脏功能和HF中的作用仍然在很大程度上未被探索.
- 这项研究调查了用于HF预测和免疫透的与茎相关的生物标志物.
研究的目的:
- 为了确定心力衰竭 (HF) 的新型茎状相关生物标志物.
- 开发HF风险分层的预测模型.
- 为了描述免疫细胞透模式在HF.
主要方法:
- 利用基因表达综合 (GEO) 数据集进行培训和验证.
- 采用机器学习算法来进行功能选择.
- 构建了名ogram模型并执行了基因本体学 (GO),基因和基因组的京都百科全书 (KEGG),基因组变异分析 (GSVA) 和基因组丰富分析 (GSEA).
主要成果:
- 鉴定了七个关键基因 (SMOC2,LUM,FNDC1,SCUBE2,CD163,BLM,S1PR3) 用于HF预测.
- 诺米图表表现出强大的预测性能.
- 关键基因与衰老和炎症有关;观察到丰富的免疫通路,突出显示了适应性免疫在高血压中的作用.
结论:
- 确定了一种临床意义上的与茎状性相关的特征,用于HF风险预测.
- 这种特征可能有助于早期诊断HF,并提高风险分层.
- 对HF患者的新型治疗策略的潜力.
相关概念视频
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...